Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Vasodialators Use-of-polyamines-as-ionic-channel-regulating-agents

 Methods for treating dermatitis using descarboethoxyloratadine
OF THE INVENTION The present invention encompasses a method of treating allergic asthma in a human ...


 Fat emulsions containing isocarbacyclin
What is claimed is: 1. A pharmaceutical prostaglandin emulsion comprising: a mixture of vegetable ...


 Dermal pharmaceutical preparations
OF THE INVENTION The support which can be used in the present invention functions to retain a ...


 Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
We claim: 1. A compound selected from the group consisting of iminodiacid compounds having the ...


 2-Azasfiro[4.(3+N)]-3-carboxylic acid derivatives, a process for their preparation, agents containing these derivatives and their use
We claim: 1. A compound of the formula I ##STR11## in which n denotes 1, 2, 3 or 4, R denotes (C....


 N-Acyl hexahydroindole-2-carboxylic acids and anti-hypertensive use thereof
We claim: 1. A compound of the formula I, ##STR24## in which n denotes 0 to 1, R denotes hydrogen, (...


 Bicyclic amino acids as intermediates in the preparation of tricyclic amino acids and processes for their preparation
We claim: 1. A compound of the formula III ##STR19## in which A denotes --CH.dbd.CH-- or --CH.sub.2 ...


 Substituted N-carboxymethyl-aminoacylaminoalkanoic acids useful as antihypertensive agents
OF THE INVENTION AND PREFERRED EMBODIMENTS In its broadest aspect, the present invention relates ...


 Racemates of optically active bicyclic imino-alpha-carboxylic esters
We claim: 1. A diasteromic salt of i. a bicyclic imino-.alpha.-carboxylic ester of the formulae Ia ...


 Disubstituted proline derivatives
We claim: 1. A compound of the formula I ##STR15## in which R.sup.1 and R.sup.2 together represent ...


 Use of polyamines as ionic-channel regulating agents

Details
Inventors: Cherksey, Bruce D.; Llinas, Rodolfo R.; Sugimori, Mutsuyuki;
Assignee: New York University (New York, NY)
Primary Examiner: Raymond; Richard L.
Assistant Examiner:
Attorney, Agent or Firm: Darby & Darby

Methods for regulating cation transport across cellular membranes possessing cation channels are provided. The cell membrane possessing a specific ion channel is exposed to a non-aromatic polyamine compound having a lysine- or arginine-based moiety (or a guanidine moiety) coupled to a straight chain polyamine. These polyamines as well as a method for regulating NMDA through a spermidine-like effect on NMDA receptors by exposing a cell membrane to selected polyamines are also provided.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The disclosure of any and all cited documents including literature and patent application is incorporated by reference in its entirety.
It is understood that in the present specification "ionic channel regulating agents" shall mean compounds and compositions which regulate flow of a cation by acting directly on a channel or by acting indirectly on it (e.
g.
, by acting on another substance or cellular structure which in turn influences the function of an ionic channel).
Further, "block" shall mean the interruption of ion transport, with direct or primary block being directly attributed to the effect of the blocking agent, while indirect (or secondary or dependent) block is a result of, or due to the action of, the direct block.
For example, direct block of a calcium channel may effectively block a potassium channel where potassium transport is dependent upon calcium transport.
In accordance with the present invention, certain nonaromatic polyamines have the ability to block calcium channels including P-type calcium channels (i.
e.
channels that display one or more of the characteristics associated with the P-channels first identified in Purkinje cells and described above).
As used herein, "polyamine" will generally refer to a compound that has (a) a dehydroxylated (or decarboxylated) arginine or lysine moiety (or a guanidine moiety) appended to (b) a straight polyamine chain moiety having two or more nitrogens separated by methylene groups.
Illustrative of polyamines useful as ionic channel regulating agents are the following compounds: ##STR2## Examples of compounds having different channel blocking activity or displaying the same type of effect as spermidine when tested i.
p.
in animals (but with substantially greater potency) include derivatives or analogs of the above-listed compounds having, e.
g.
, a dehydroxylated or decarboxylated lysine moiety.
Illustrative of polyamines useful as such regulating agents are the following compounds: ##STR3## wherein x and y are integers independently selected from 3 or 4 and wherein Z is a carbonyl, CH



Related patents
  Inhibitor of ceramidase
It is a general object of the invention to provide a method of selecting compounds that cause intracellular accumulation of ceramide. It is a specific object of the ...
  Treatment of bone disorders with adrenomedullin
OF THE INVENTION It is believed that one skilled in the art can, based on the description herein, utilize the present invention to its fullest extent. The following ...
  99MTC(III) myocardial imaging agents and method of use
OF THE INVENTION The technetium compounds of the present invention which have been found most useful as myocardial imaging agents in humans comprise hexadentate ...
  1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
OF THE INVENTION Compounds of the formula I may be prepared as illustrated in the following reaction scheme. ##STR6## Referring to the above reaction scheme, compounds ...
  Vaginal sponge delivery system
These and other objects of the invention are achieved in a product which broadly comprises (a) a sealed, air-tight package, enclosing therein (b) a sponge impregnated ...
  Controlled release formulation
What is claimed is: 1. In a controlled release angiotensin converting enzyme inhibitor formulation in the form of an uncoated tablet from which upon ingestion ...
  Formulations providing three distinct releases
We claim: 1. A therapeutic composition for oral administration consisting essentially of a pharmaceutical gelatin capsule containing film coated spheroids, which ...
  Floating sustained release therapeutic compositions
OF THE INVENTION According to the present invention, therapeutic dosage forms have now been discovered which are easy to prepare, provide sustained release of contained ...
  Solid oral dosage forms of ifosfamide
OF PREFERRED EMBODIMENTS The invention is illustrated by the following examples: EXAMPLE 1 Ifosfamide capsule mass In accordance with the invention, the capsule mass is ...
  [(benzodioxan, benzofuran or benzopyran) alkylamino] alkyl substituted guanidines
We claim: 1. A compound of the formula: ##STR259## a pharmaceutically acceptable acid addition salt thereof, or a stereochemically isomeric form thereof, wherein: X is O,...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved